174 related articles for article (PubMed ID: 30446181)
1. Association of elevated circulating fibroblast growth factor 21 levels with prevalent and incident metabolic syndrome: The Multi-Ethnic Study of Atherosclerosis.
Ong KL; McClelland RL; Allison MA; Kokkinos J; Wu BJ; Barter PJ; Rye KA
Atherosclerosis; 2019 Feb; 281():200-206. PubMed ID: 30446181
[TBL] [Abstract][Full Text] [Related]
2. The relationship of circulating fibroblast growth factor 21 levels with incident atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis.
Hui TH; McClelland RL; Allison MA; Rodriguez CJ; Kronmal RA; Heckbert SR; Michos ED; Barter PJ; Rye KA; Ong KL
Atherosclerosis; 2018 Feb; 269():86-91. PubMed ID: 29351855
[TBL] [Abstract][Full Text] [Related]
3. Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: Multi-Ethnic Study of Atherosclerosis.
Ong KL; Campbell S; Wu BJ; McClelland RL; Kokkinos J; Szklo M; Polak JF; Allison MA; Rye KA
Atherosclerosis; 2019 Aug; 287():46-53. PubMed ID: 31212234
[TBL] [Abstract][Full Text] [Related]
4. Serum Fibroblast Growth Factor 21 and New-Onset Metabolic Syndrome: KoGES-ARIRANG Study.
Choi JR; Kim JY; Park IH; Huh JH; Kim KW; Cha SK; Park KS; Sohn JH; Park JT; Koh SB
Yonsei Med J; 2018 Mar; 59(2):287-293. PubMed ID: 29436198
[TBL] [Abstract][Full Text] [Related]
5. Relationship of fibroblast growth factor 21 with kidney function and albuminuria: multi-ethnic study of atherosclerosis.
Anuwatmatee S; Allison MA; Shlipak MG; McClelland RL; Kramer H; Tang S; Hou L; Rye KA; Ong KL
Nephrol Dial Transplant; 2019 Jun; 34(6):1009-1016. PubMed ID: 29771383
[TBL] [Abstract][Full Text] [Related]
6. The association of circulating fibroblast growth factor 21 levels with incident heart failure: The Multi-Ethnic Study of Atherosclerosis.
Tucker W; McClelland RL; Allison MA; Szklo M; Rye KA; Ong KL
Metabolism; 2023 Jun; 143():155535. PubMed ID: 36931558
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events.
Wu L; Qian L; Zhang L; Zhang J; Zhou J; Li Y; Hou X; Fang Q; Li H; Jia W
J Am Heart Assoc; 2020 Jun; 9(11):e015226. PubMed ID: 32431189
[TBL] [Abstract][Full Text] [Related]
8. Relationship of fibroblast growth factor 21 levels with inflammation, lipoproteins and non-alcoholic fatty liver disease.
Tucker B; McClelland RL; Allison MA; Budoff MJ; Wu BJ; Barter PJ; Rye KA; Ong KL
Atherosclerosis; 2020 Apr; 299():38-44. PubMed ID: 32220662
[TBL] [Abstract][Full Text] [Related]
9. Association of circulating fibroblast growth factor 21 levels with all-cause and cardiovascular mortality: The multi-ethnic study of atherosclerosis.
Tucker WJ; Tucker B; Januszewski AS; Jenkins AJ; Keech AC; Kestenbaum BR; Allison MA; Rye KA; Ong KL
Clin Chim Acta; 2024 Mar; 555():117799. PubMed ID: 38309558
[TBL] [Abstract][Full Text] [Related]
10. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study.
Shah RV; Murthy VL; Abbasi SA; Blankstein R; Kwong RY; Goldfine AB; Jerosch-Herold M; Lima JA; Ding J; Allison MA
JACC Cardiovasc Imaging; 2014 Dec; 7(12):1221-35. PubMed ID: 25440591
[TBL] [Abstract][Full Text] [Related]
11. Impact of Race on the Association of Mineral Metabolism With Heart Failure: the Multi-Ethnic Study of Atherosclerosis.
Robinson-Cohen C; Shlipak M; Sarnak M; Katz R; Peralta C; Young B; Hoofnagle AN; Szklo M; Ix JH; Psaty BM; de Boer IH; Kestenbaum B; Bansal N
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1144-51. PubMed ID: 31760429
[TBL] [Abstract][Full Text] [Related]
12. Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus.
Lee CH; Woo YC; Chow WS; Cheung CYY; Fong CHY; Yuen MMA; Xu A; Tse HF; Lam KSL
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588089
[TBL] [Abstract][Full Text] [Related]
13. Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease.
Shen Y; Ma X; Zhou J; Pan X; Hao Y; Zhou M; Lu Z; Gao M; Bao Y; Jia W
Cardiovasc Diabetol; 2013 Aug; 12():124. PubMed ID: 23981342
[TBL] [Abstract][Full Text] [Related]
14. Patterns of clustering of the metabolic syndrome components and its association with coronary heart disease in the Multi-Ethnic Study of Atherosclerosis (MESA): A latent class analysis.
Riahi SM; Moamer S; Namdari M; Mokhayeri Y; Pourhoseingholi MA; Hashemi-Nazari SS
Int J Cardiol; 2018 Nov; 271():13-18. PubMed ID: 29885819
[TBL] [Abstract][Full Text] [Related]
15. The association between HDL particle concentration and incident metabolic syndrome in the multi-ethnic Dallas Heart Study.
Mani P; Ren HY; Neeland IJ; McGuire DK; Ayers CR; Khera A; Rohatgi A
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1(Suppl 1):S175-S179. PubMed ID: 27993539
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart Study.
DeBoer MD; Filipp SL; Musani SK; Sims M; Okusa MD; Gurka M
Kidney Blood Press Res; 2018; 43(2):555-567. PubMed ID: 29642060
[TBL] [Abstract][Full Text] [Related]
17. Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children.
Ko BJ; Kim SM; Park KH; Park HS; Mantzoros CS
Int J Obes (Lond); 2014 Dec; 38(12):1497-502. PubMed ID: 24638201
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of soluble receptor for advanced glycation end-products and metabolic syndrome: the Northern Manhattan Study.
Hudson BI; Dong C; Gardener H; Elkind MS; Wright CB; Goldberg R; Sacco RL; Rundek T
Metabolism; 2014 Sep; 63(9):1125-30. PubMed ID: 25012910
[TBL] [Abstract][Full Text] [Related]
19. The relationship of circulating fibroblast growth factor 21 levels with pericardial fat: The Multi-Ethnic Study of Atherosclerosis.
Magdas A; Ding J; McClelland RL; Allison MA; Barter PJ; Rye KA; Ong KL
Sci Rep; 2019 Nov; 9(1):16423. PubMed ID: 31712677
[TBL] [Abstract][Full Text] [Related]
20. Association Between High-Sensitivity C-Reactive Protein and Metabolic Syndrome Among Hispanic/Latino Participants of the Hispanic Community Health Study/Study of Latinos.
Mesa RA; Damas OM; Schneiderman N; Palacio AM; Gallo LC; Talavera GA; Sotres-Alvarez D; Daviglus ML; Pirzada A; Llabre MM; Elfassy T
Metab Syndr Relat Disord; 2024 Jun; 22(5):327-336. PubMed ID: 38563777
[No Abstract] [Full Text] [Related]
[Next] [New Search]
